These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7624265)

  • 41. [Mesalazine].
    Netzer P
    Dtsch Med Wochenschr; 1996 Jan; 121(1-2):42. PubMed ID: 8565806
    [No Abstract]   [Full Text] [Related]  

  • 42. Mesalazine-associated interstitial nephritis.
    World MJ; Stevens PE; Ashton MA; Rainford DJ
    Nephrol Dial Transplant; 1996 Apr; 11(4):614-21. PubMed ID: 8671848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment and recurrence prevention ulcerative colitis].
    Schölmerich J
    Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
    Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fever and hypotension following oral administration of mesalazine].
    Galofré N; Cirera I; Supervía A; Peña MJ
    Med Clin (Barc); 1995 Mar; 104(9):358. PubMed ID: 7731308
    [No Abstract]   [Full Text] [Related]  

  • 46. [Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
    Martínez González J; Busto Bea V; Mesonero Gismero F; Parejo Carbonell S; Garrido E; López San Román A
    Gastroenterol Hepatol; 2013 Jan; 36(1):7-10. PubMed ID: 23195755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How safe are the safest IBD drugs?
    Lewis JD
    Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
    [No Abstract]   [Full Text] [Related]  

  • 48. [Mesalazine].
    Engelhardt K; Mohr K
    Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
    [No Abstract]   [Full Text] [Related]  

  • 49. [Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia].
    Bielecki JW; Avar S; Joss R
    Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1078-83. PubMed ID: 10971941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 51. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
    García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
    Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 53. Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs.
    Takaya T; Sawada K; Suzuki H; Funaoka A; Matsuda K; Takada K
    J Drug Target; 1997; 4(5):271-6. PubMed ID: 9169983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Secondary blood dyscrasias due to drugs and chemical agents. Study in patients hospitalized in the Hematology Service of the Hospital das Clínicas of the F.M.U.S.P. from 1955 to 1975].
    de Cillo DM; Santana MO; Mori NS; Jamra M
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Feb; 33(1):33-8. PubMed ID: 307268
    [No Abstract]   [Full Text] [Related]  

  • 55. Aminosalicylates: old and new.
    Hanauer SB
    Mt Sinai J Med; 1990 Oct; 57(5):283-7. PubMed ID: 1982892
    [No Abstract]   [Full Text] [Related]  

  • 56. Mesalazine-associated interstitial nephritis.
    Mani V
    Nephrol Dial Transplant; 1997 Mar; 12(3):622-3. PubMed ID: 9075162
    [No Abstract]   [Full Text] [Related]  

  • 57. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
    Farr M; Symmons DP; Blake DR; Bacon PA
    Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple haematologic abnormalities associated with sulfasalazine.
    Wheelan KR; Cooper B; Stone MJ
    Ann Intern Med; 1982 Nov; 97(5):726-7. PubMed ID: 6127975
    [No Abstract]   [Full Text] [Related]  

  • 59. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine.
    Skhiri H; Knebelmann B; Martin-Lefevre L; Grunfeld JP
    Nephron; 1998; 79(2):236. PubMed ID: 9647514
    [No Abstract]   [Full Text] [Related]  

  • 60. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Logan RF; van Staa TP
    Gut; 2003 Oct; 52(10):1530; author reply 1530-1. PubMed ID: 12970150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.